News & Analysis
- Data & Tools
- Login | Register
Aaron F Barkoff is a shareholder at McAndrews, focusing on pharmaceutical and biotechnology patent litigation. He has extensive trial experience in abbreviated new drug application litigation, representing both generic and brand-name drug companies. Recently, he was lead trial and appeal counsel for Piramal Healthcare in Amgen v Amneal. He has also successfully represented both patent owners and petitioners as lead counsel in inter partes reviews. Dr Barkoff’s strong technical background (PhD in biochemistry), combined with his deep understanding of Food and Drug Administration (FDA) regulatory issues, enables him to provide life sciences companies with keen insights on patent litigation strategy, including biosimilar litigation strategy under the Biologics Price Competition and Innovation Act. He also advises clients on Orange Book patent listings, patent term extensions and FDA exclusivity.
Get unlimited access to all IAM content